Watson Fund

Watson Fund, L.P. is a healthcare venture capital fund founded in 2013 and headquartered in Seattle, Washington, that specializes in early-stage investments across a broad range of life science opportunities. The fund primarily invests in biotechnology and life science opportunities developed and managed by Accelerator Corporation (now Accelerator Life Science Partners), a Seattle-based life science investment and management firm, with reserves allocated for follow-on investments in companies that meet pre-defined development milestones. The firm has made investments in companies including Proniras Corporation and Rodeo Therapeutics (its most recent portfolio exit), and its co-investors include ARCH Venture Partners, AbbVie Ventures, Eli Lilly and Company, and WRF Capital.